Victoria Nash

Victoria Nash, PhD, is an Assistant Research Professor in Drexel University’s School of Biomedical Engineering, Science and Health Systems. Dr. Nash's career began in industry, working for Moderna in Cambridge, MA. There, she gained valuable insight into vaccine design and pre-clinical production before returning to academia. During her studies towards her master's degree, Dr. Nash participated in the co-op program at Drexel and was fortunate enough to be the first student to do a co-op at Spark Therapeutics, working in Upstream Process Development. She deepened her knowledge in gene therapy as she worked alongside the industry experts who created the first FDA approved gene therapy to cure childhood blindness. While Dr. Nash enjoyed her work at Spark, she decided to stay in academia to complete her PhD in biomaterials and regenerative medicine, while advised by Kara Spiller, PhD. Her work now focuses on immunomodulatory biomaterials and novel applications of gene and cell therapies.